Gene · 3601
Papers2,328
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,328
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| What Can De Novo Protein Design Bring to the Treatment of Hematological Disorders? | Biology (Basel) | 2023 | 36829445 | PubTator, text mining | PubMed |
| Mapping the interplay between NK cells and HIV: therapeutic implications. | J Leukoc Biol | 2023 | 36822173 | PubTator, text mining | PubMed |
| IL-15 enhances HIV-1 infection by promoting survival and proliferation of CCR5+CD4+ T cells. | JCI Insight | 2023 | 36821374 | PubTator, text mining | PubMed |
| Rabies virus uniquely reprograms the transcriptome of human monocyte-derived macrophages. | Front Cell Infect Microbiol | 2023 | 36798087 | PubTator, text mining | PubMed |
| NK cells are never alone: crosstalk and communication in tumour microenvironments. | Mol Cancer | 2023 | 36797782 | PubTator, text mining | PubMed |
| Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions. | Signal Transduct Target Ther | 2023 | 36797231 | PubTator, text mining | PubMed |
| IL15 modification enables CAR T cells to act as a dual targeting agent against tumor cells and myeloid-derived suppressor cells in GBM. | J Immunother Cancer | 2023 | 36759014 | PubTator, text mining | PubMed |
| Barrier-to-autointegration factor 1 promotes gammaherpesvirus reactivation from latency. | Nat Commun | 2023 | 36746947 | PubTator, text mining | PubMed |
| Integrated analysis of ATAC-seq and RNA-seq reveals the transcriptional regulation network in SLE. | Int Immunopharmacol | 2023 | 36738683 | PubTator, text mining | PubMed |
| Macrophage and monocyte subsets as new therapeutic targets in cancer immunotherapy. | ESMO Open | 2023 | 36731326 | PubTator, text mining | PubMed |
| Multiplex immune profiling reveals the role of serum immune proteomics in predicting response to preoperative chemotherapy of gastric cancer. | Cell Rep Med | 2023 | 36724786 | PubTator, text mining | PubMed |
| Social Safety Theory: Conceptual foundation, underlying mechanisms, and future directions. | Health Psychol Rev | 2023 | 36718584 | PubTator, text mining | PubMed |
| Interleukin-2 family cytokines: An overview of genes, expression, signaling and functional roles in teleost. | Dev Comp Immunol | 2023 | 36696924 | PubTator, text mining | PubMed |
| Spatial molecular and cellular determinants of STAT3 activation in liver fibrosis progression in non-alcoholic fatty liver disease. | JHEP Rep | 2023 | 36687470 | PubTator, text mining | PubMed |
| Preclinical evaluation of IAP0971, a novel immunocytokine that binds specifically to PD1 and fuses IL15/IL15Rα complex. | Antib Ther | 2023 | 36683766 | PubTator, text mining | PubMed |
| New Developments in Celiac Disease Treatment. | Int J Mol Sci | 2023 | 36674460 | PubTator, text mining | PubMed |
| Alopecia Areata: A Review of the Role of Oxidative Stress, Possible Biomarkers, and Potential Novel Therapeutic Approaches. | Antioxidants (Basel) | 2023 | 36670997 | PubTator, text mining | PubMed |
| INBRX-120, a CD8α-targeted detuned IL-2 that selectively expands and activates tumoricidal effector cells for safe and durable in vivo responses. | J Immunother Cancer | 2023 | 36653071 | PubTator, text mining | PubMed |
| Soluble CD25 imposes a low-zone IL-2 signaling environment that favors competitive outgrowth of antigen-experienced CD25high regulatory and memory T cells. | Cell Immunol | 2023 | 36642016 | PubTator, text mining | PubMed |
| Humanized mouse models for immuno-oncology research. | Nat Rev Clin Oncol | 2023 | 36635480 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3601/papers?page=18